Provyx vs. IQVIA OneKey: Provider Data Compared
Compare IQVIA and Provyx against the same use case, fields, evidence standard, and delivery workflow. Review the current IQVIA OneKey documentation alongside the written Provyx scope before deciding.
Updated April 2026
IQVIA OneKey vs. Provyx at a Glance
| Factor | IQVIA OneKey | Provyx |
|---|---|---|
| Starting Price | Confirm in current vendor documentation or a written quote | Verify the measured value and observation date before use. |
| Contract Terms | Annual or multi-year Lock-In | |
| Healthcare Focus | Deep pharma analytics + HCP data Pharma-Grade | Provider business contacts NPI-Verified |
| NPI Verification | Proprietary surveys + claims Verified | CMS NPI Registry Every Record |
| specialty filtering | Platform-only OneKey UI | specialty and subspecialty coverage On Export |
| Data Delivery | Platform, API, custom Implementation needed | CSV or Excel Self-Serve |
| Best For | Pharma teams needing prescribing data + global HCP coverage | Sales/marketing teams needing clean provider contact data |
| Key Risk | Confirm in current vendor documentation or a written quote | No Rx data, no claims, US only Contact Data Only |
IQVIA OneKey
IQVIA OneKey
Enterprise Pharma Product
IQVIA OneKey is designed for pharma commercial operations at scale. The prescribing data, claims analytics, and global coverage are unmatched. However, most of that capability is irrelevant to a team whose job is building outreach lists rather than managing drug brand strategy.
IQVIA OneKey Product Scope
OneKey, which IQVIA acquired when it was known as SK&A, is a healthcare professional (HCP) and healthcare organization (HCO) reference database. According to IQVIA's website, OneKey covers approximately 9 million healthcare professionals globally across more than 80 countries. That global footprint is a genuine differentiator. If your sales team operates across the EU, Asia-Pacific, and Latin America, few databases can match that reach.
The core of OneKey is provider identity resolution. IQVIA assigns each healthcare professional a unique identifier and links that professional to their organizational affiliations, specialties, and geographic locations. For pharma companies running multi-channel commercial campaigns, this identity layer matters because it connects prescribing behavior to individual providers. When your field reps visit a physician, your digital team emails that same physician, and your managed markets team engages the health system where they practice, the OneKey ID ties all of those interactions to a single profile. This is harder to replicate than it sounds.
IQVIA's data sourcing is also distinct from most competitors. They combine proprietary physician surveys, pharmacy claims data, hospital discharge records, and commercial databases to build their provider profiles. This multi-source approach gives them data points that public registries don't contain, particularly around prescribing behavior, patient panel size estimates, and clinical activity indicators. The tradeoff is that this proprietary sourcing makes it harder for customers to independently verify the underlying data.
Beyond OneKey, IQVIA offers analytics platforms, real-world evidence studies, clinical trial design and recruitment, and consulting services. Their technology stack includes the Orchestrated Customer Engagement (OCE) platform for commercial teams, which integrates CRM functionality with their data assets. For a large pharma commercial organization, this integration between data, analytics, and execution tools can be valuable. The purchase amounts to an ecosystem where your CRM, your analytics dashboards, and your provider data all speak the same language.
IQVIA also maintains strong compliance frameworks. These are experienced in navigating healthcare data regulations across multiple jurisdictions, including GDPR in Europe and various state-level privacy laws in the U.S. For enterprise buyers with legal teams that scrutinize every vendor, IQVIA's compliance posture is a meaningful advantage. They've been through thousands of enterprise procurement reviews, and their security documentation and data processing agreements reflect that experience. Source: IQVIA OneKey documentation.
Pricing and Contracts
Where IQVIA Falls Short for Provider Contact Data Buyers
Run IQVIA OneKey and Provyx against the same provider sample and the same target fields. Check identity, current practice, specialty, business contact channels, unresolved records, and import effort separately. The comparison should show which product fits the planned workflow, not collapse reference-data breadth and campaign readiness into one score.
✓ Strengths
- Prescribing data linked to individual providers (unmatched)
- Claims-based analytics and referral pattern mapping
- Deep pharma commercial intelligence and brand tracking
- Proprietary HCP identity resolution across channels
✗ Weaknesses
- Long implementation timelines (months rather than days)
- Requires dedicated analyst resources to operate
- Overkill if you only need provider contact records
Sources and References
Provyx
Provyx
What Provyx Delivers
Provyx is a healthcare provider verification and enrichment service. We build verified contact records for healthcare providers in the United States: NPI numbers, email addresses, phone numbers, practice addresses, and organizational affiliations. Our data is sourced from the public CMS NPI Registry, business listings, and commercial databases, then verified and enriched before delivery.
Every record in Provyx is matched against the CMS NPI Registry to confirm that the provider holds an active NPI and that their specialty classification is current. You can filter by any of the provider specialties and subspecialties, which means you can pull records for pediatric cardiologists in Texas or orthopedic surgeons within 50 miles of Chicago without wading through irrelevant specialties.
We should be upfront about what Provyx does not offer. We don't have prescribing data. We don't offer claims analytics, clinical trial services, or real-world evidence platforms. We don't cover providers outside the United States. We're not trying to be an all-in-one healthcare intelligence platform. If those capabilities are requirements for your team, Provyx isn't the right fit, and IQVIA likely is.
How Provyx Handles Healthcare Provider Business Data
Healthcare provider business data has specific requirements that general-purpose B2B data tools weren't built to handle. NPI numbers are the universal identifier in U.S. Healthcare, and any provider database that doesn't verify against the CMS NPI Registry is guessing. Provyx treats NPI verification as the foundation of every build. Every record we deliver has been checked against the CMS NPI Registry to confirm the NPI is active and the associated specialty classifications are current.
Practice-level location data matters too. Many providers practice at multiple locations, and the address attached to their NPI registration may not be the best address for sales outreach. A surgeon's NPI might list their hospital system's administrative office; however, your rep needs the ambulatory surgery center where they operate three days a week. Provyx maps providers to their practice locations using business listing data and commercial databases, giving you the practice address where they see patients, beyond their billing address.
For healthcare marketing agencies running campaigns across multiple specialties and geographies, this granularity is the difference between relevant outreach and spray-and-pray. For medical device reps who need to identify orthopedic surgeons at ambulatory surgery centers within their territory; this is the difference between a productive week and a wasted one. And for healthcare SaaS vendors trying to reach practice managers and group practice decision-makers, classification and location filtering lets you target the right practice types without manually sorting through thousands of irrelevant records.
We also recognize that healthcare data carries regulatory considerations. While Provyx deals exclusively in business contact data (not patient health information), we maintain clear data sourcing documentation and processing standards. Every record traces back to public registries, business listings, or commercial data sources. We don't scrape social media, and we don't use patient encounter data to enrich provider records. When your compliance team asks where the data comes from, you get a clear answer. Source: current Provyx scope and pricing.
Pricing
Provyx uses project-based pricing. You pay for the contacts delivered with a validated email, and that's it. There are no annual contracts, no seat licenses, no recurring commitments, and no implementation fees. You sign up, filter the providers you need by specialty classifications and geography, and pull records. Your cost scales directly with your usage. Source: current Provyx scope and pricing.
There are no seats to manage, either. Your entire team can access Provyx under one account. We don't charge per user because the number of people on your team who need to pull data has nothing to do with how much data you're using. Seat-based pricing serves the vendor's revenue model far better than it serves the customer. Source: current Provyx scope and pricing.
You can see current pricing on our pricing page. We publish it publicly because hidden pricing mostly protects the vendor's margin. If you want to know what Provyx costs, you shouldn't have to sit through a sales call to find out. Source: current Provyx scope and pricing.
✓ Strengths
- Records checked against the CMS NPI Registry
- Self-serve: order data and receive it in days rather than months
- Per-contact pricing with no annual commitment
- Practice-level data including direct phone, fax, address
- provider specialties and subspecialties for specialty filtering
✗ Honest Limitations
- No prescribing or Rx data
- No claims analytics or referral network mapping
- US healthcare providers only, no global coverage
- No HCP identity resolution across marketing channels
Stage-Specific Customer Fit
General B2B Teams
Healthcare-Focused Teams
Enterprise Teams
Run IQVIA OneKey and Provyx against the same provider sample and the same target fields. Check identity, current practice, specialty, business contact channels, unresolved records, and import effort separately. The comparison should show which product fits the planned workflow, not collapse reference-data breadth and campaign readiness into one score.
Our Recommendation
The Bottom Line
This comparison comes down to what you need the data for.
The smart play:
- Pharma commercial teams: If you need prescribing data, claims analytics, and global HCP coverage, IQVIA OneKey is the right tool. Nothing else matches it at scale.
- Sales/marketing teams: If you need clean contact lists for healthcare outreach, Provyx delivers NPI-verified records without the enterprise overhead or six-figure price tag. Source: current Provyx scope and pricing.
- Pharma teams needing both: Use IQVIA for commercial strategy and prescriber analytics, and Provyx for tactical outreach execution where you need practice-level contacts quickly.
Questions to Ask Before Signing
- Do you need prescribing data?: If no, you're paying for IQVIA's most expensive capability without using it.
- Keep measured values only when the source, scope, and observation date travel with the record.
How should the IQVIA OneKey comparison be handed to operations?
Keep three clear review outcomes for each relevant disputed field: accepted, rejected, and unresolved. Do not force an uncertain match into either of the first two groups. Accepted values can move into the destination workflow, rejected values can be excluded, and unresolved values can enter a review queue with the conflicting sources preserved. The same labels should be used for IQVIA OneKey and Provyx so the comparison reflects evidence rather than different grading rules.
For IQVIA OneKey, finish with a repeatable refresh plan. Save the source date, the check method, and the reason each volatile field matters to the campaign. Recheck the fields that can change before the next outreach cycle, then compare the new sample with the baseline. If the failure pattern changes, update the acceptance rule and document why. Keep the rejected and unresolved rows too, because they reveal whether the same identity, location, or contact problem returns. Review that evidence with the workflow owner before changing a global rule. A local exception should remain local unless the broader sample supports the change. That feedback loop makes the selection useful after procurement and gives the team a defensible way to reassess the decision later.
What belongs in the compare provyx vs iqvia evaluation record?
The compare provyx vs iqvia evaluation record should begin with the job the data will perform. Name the audience, destination workflow, fields used by that workflow, and the source that resolves conflicting values. Keep provider identity separate from practice identity, and keep both separate from the parent organization. That structure lets the review team see whether a failure belongs to the person, the location, the relationship, or the contact channel.
Define the acceptance rule before reviewing a sample
Keep disagreements visible
Test the operating handoff
Preserve a baseline for the next review
Define the reference-data boundary first
Write down whether the operating need is domestic outreach, global reference management, affiliation resolution, omnichannel coordination, or a combination. Those jobs demand different identifiers, field definitions, governance, and integration paths. A useful comparison keeps them separate instead of collapsing them into one provider-data score.
Build a sample with known provider and organization relationships, multiple locations, name variants, and recent changes. Score identity, affiliations, specialty, business contacts, provenance, and unresolved records independently. For global work, document the local authority and meaning of each field before comparing coverage across countries.
Test identity and delivery together
Map the selected identifiers into a disposable destination and inspect how updates, merges, and corrections behave. Preserve the vendor value, internal value, source date, and resolution decision. The team should be able to reverse a bad match without losing the earlier evidence.
Include security, access, and stewardship owners in the evaluation record. Name who can change field rules, who reviews exceptions, and how downstream teams learn about an updated relationship. Reference data becomes operational only when those responsibilities travel with the integration.
Define the geography and relationship model first
A global reference-data requirement differs from a domestic campaign file. Identify the countries, entity types, language needs, organization hierarchies, and downstream systems before comparing samples. State which identifiers and relationships need to remain consistent across markets and which fields can follow local definitions.
For the outreach workflow, select clinicians and organizations from the actual specialties and care settings in scope. Include multi-location providers, renamed organizations, parent-child relationships, and records with sparse public contact information. Score identity, affiliation, practice location, and business channels independently.
Inspect receiving-system governance
Map both samples into a disposable destination. Review identifiers, source dates, update precedence, merges, deletes, rejected rows, and the route for corrections. Ask who can change an accepted value and whether the original observation remains available after normalization.
The final recommendation should name the system of record for each accepted field. If a reference-data platform owns identity while another workflow supplies campaign contacts, document the join key, refresh sequence, and treatment of conflicts. This boundary matters more than a broad feature count.
Frequently Asked Questions
Can Provyx replace IQVIA for pharma commercial teams?
Not if you need prescribing data, claims analytics, or global HCP coverage. IQVIA's prescribing intelligence is unique at their scale and directly informs territory planning and field force deployment for pharma brands. Provyx can replace IQVIA for the contact data component if that's all you need; however, the analytics layer is a different category entirely. A combined workflow can use IQVIA for analytics, Provyx for day-to-day contact pulls. Source: https://www.iqvia.com/solutions/commercialization/data-and-information-management/onekey/onekey-hcp-reference-data.
How does NPI verification differ between Provyx and IQVIA?
Provyx verifies every record against the public CMS NPI Registry to confirm active NPI status and current specialty classification. IQVIA uses a combination of proprietary surveys, claims data matching, and their own verification processes. Both approaches produce verified records; however, Provyx's method is transparent and tied directly to the federal registry that providers are legally needed to maintain. Source: CMS NPPES files. Source: https://www.iqvia.com/solutions/commercialization/data-and-information-management/onekey/onekey-hcp-reference-data.
How should a team define the comparison sample?
Choose representative specialties, organizations, geographies, and destination workflows. Score reference identity, affiliations, business contacts, provenance, and unresolved records as separate dimensions. Source: IQVIA OneKey reference data.
Which integration details belong in the test?
Document identifiers, field mapping, update behavior, rejected records, access controls, and the owner of exceptions. Test the handoff in a disposable destination before approving the operating design. Source: IQVIA OneKey reference data.
How should global and domestic workflows be separated?
Define the countries, source authorities, privacy review, and local field meanings before comparing coverage. A domestic outreach sample cannot establish suitability for a global reference-data program. Source: IQVIA OneKey reference data.
Get the Provider Data You Need
Tell us what you're looking for. We'll build a custom list matched to your target market.
Trusted by healthcare sales teams, medical device companies, and health IT vendors across the US.
Check localization and stewardship requirements
For each market, document language, address conventions, permitted field values, local identifiers, and the team responsible for resolving discrepancies. Test whether global organization relationships remain intelligible when viewed by a local operator.
Include a change scenario in the evaluation: a provider moves, an organization merges, or a local practice changes its public name. Trace how the observation enters the reference record, reaches the receiving system, and appears to downstream users. Preserve the earlier value and its date when history matters to account ownership.
Review access and correction roles with the data steward. The evaluation record should state who can propose, approve, and distribute a change, plus how unresolved relationships are represented. This makes governance comparable without treating broad geographic coverage as proof of workflow fit. Include the local operator's review notes. Have that operator trace an ambiguous affiliation from the source record through normalization and into the consuming application. Document where the local meaning is preserved, translated, or lost, and assign the unresolved step to a named steward.